|
UBA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.975800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.615190E-01 |
| Normal-vs-Stage2 |
6.212800E-01 |
| Normal-vs-Stage3 |
6.994600E-01 |
| Normal-vs-Stage4 |
4.908600E-01 |
| Stage1-vs-Stage2 |
1.225150E-01 |
| Stage1-vs-Stage3 |
3.560800E-01 |
| Stage1-vs-Stage4 |
6.502200E-01 |
| Stage2-vs-Stage3 |
4.252200E-01 |
| Stage2-vs-Stage4 |
3.059600E-01 |
| Stage3-vs-Stage4 |
7.578800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.053000E-01 |
| Normal-vs-AfricanAmerican |
2.241600E-01 |
| Normal-vs-Asian |
2.737400E-01 |
| Caucasian-vs-AfricanAmerican |
4.008000E-01 |
| Caucasian-vs-Asian |
6.503400E-01 |
| AfricanAmerican-vs-Asian |
6.702400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.282800E-01 |
| Normal-vs-Female |
1.828160E-01 |
| Male-vs-Female |
1.883840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.040220E-01 |
| Normal-vs-Age(41-60Yrs) |
7.401200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.332600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.919020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.333590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.687830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.118400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.232200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.839200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.309000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.886400E-01 |
| Classical-VS-Follicular |
1.90629999999858E-05 |
| Classical-VS-Other |
2.438200E-01 |
| Classical-VS-Normal |
2.472100E-02 |
| Tall-VS-Follicular |
3.198300E-02 |
| Tall-VS-Other |
3.445800E-01 |
| Tall-VS-Normal |
2.340200E-01 |
| Follicular-VS-Other |
7.858200E-01 |
| Follicular-VS-Normal |
1.251620E-01 |
| Other-VS-Normal |
6.650400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.251200E-01 |
| Normal-vs-N1 |
9.764000E-01 |
| N0-vs-N1 |
7.663800E-01 |
|
|
